CONMED ROE 2010-2023 | CNMD
Current and historical return on equity (ROE) values for CONMED (CNMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| CONMED ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2023-12-31 |
$0.07B |
$0.83B |
8.22% |
| 2023-09-30 |
$0.06B |
$0.80B |
7.68% |
| 2023-06-30 |
$0.09B |
$0.78B |
11.89% |
| 2023-03-31 |
$-0.09B |
$0.75B |
-12.89% |
| 2022-12-31 |
$-0.08B |
$0.75B |
-10.94% |
| 2022-09-30 |
$-0.08B |
$0.72B |
-11.20% |
| 2022-06-30 |
$-0.11B |
$0.67B |
-15.18% |
| 2022-03-31 |
$0.07B |
$0.79B |
8.72% |
| 2021-12-31 |
$0.06B |
$0.79B |
8.24% |
| 2021-09-30 |
$0.06B |
$0.76B |
8.45% |
| 2021-06-30 |
$0.05B |
$0.74B |
7.55% |
| 2021-03-31 |
$0.01B |
$0.73B |
2.01% |
| 2020-12-31 |
$0.01B |
$0.71B |
1.44% |
| 2020-09-30 |
$0.00B |
$0.68B |
0.14% |
| 2020-06-30 |
$0.00B |
$0.68B |
0.14% |
| 2020-03-31 |
$0.03B |
$0.70B |
4.84% |
| 2019-12-31 |
$0.03B |
$0.71B |
4.14% |
| 2019-09-30 |
$0.03B |
$0.70B |
4.36% |
| 2019-06-30 |
$0.03B |
$0.70B |
4.29% |
| 2019-03-31 |
$0.03B |
$0.69B |
4.82% |
| 2018-12-31 |
$0.04B |
$0.66B |
6.45% |
| 2018-09-30 |
$0.07B |
$0.65B |
11.34% |
| 2018-06-30 |
$0.07B |
$0.65B |
11.78% |
| 2018-03-31 |
$0.07B |
$0.64B |
11.61% |
| 2017-12-31 |
$0.06B |
$0.63B |
9.25% |
| 2017-09-30 |
$0.02B |
$0.59B |
2.58% |
| 2017-06-30 |
$0.02B |
$0.58B |
2.58% |
| 2017-03-31 |
$0.01B |
$0.58B |
2.07% |
| 2016-12-31 |
$0.02B |
$0.58B |
2.58% |
| 2016-09-30 |
$0.02B |
$0.58B |
2.75% |
| 2016-06-30 |
$0.02B |
$0.58B |
3.10% |
| 2016-03-31 |
$0.02B |
$0.58B |
3.79% |
| 2015-12-31 |
$0.03B |
$0.59B |
5.19% |
| 2015-09-30 |
$0.03B |
$0.58B |
5.71% |
| 2015-06-30 |
$0.03B |
$0.58B |
4.47% |
| 2015-03-31 |
$0.03B |
$0.57B |
4.94% |
| 2014-12-31 |
$0.03B |
$0.58B |
5.40% |
| 2014-09-30 |
$0.03B |
$0.59B |
5.18% |
| 2014-06-30 |
$0.04B |
$0.60B |
5.85% |
| 2014-03-31 |
$0.04B |
$0.60B |
5.89% |
| 2013-12-31 |
$0.04B |
$0.61B |
6.05% |
| 2013-09-30 |
$0.04B |
$0.59B |
6.21% |
| 2013-06-30 |
$0.04B |
$0.59B |
6.69% |
| 2013-03-31 |
$0.04B |
$0.60B |
6.67% |
| 2012-12-31 |
$0.04B |
$0.61B |
6.70% |
| 2012-09-30 |
$0.00B |
$0.60B |
0.68% |
| 2012-06-30 |
$0.00B |
$0.59B |
0.51% |
| 2012-03-31 |
$0.00B |
$0.59B |
0.34% |
| 2011-12-31 |
$0.00B |
$0.57B |
0.17% |
| 2011-09-30 |
$0.03B |
$0.61B |
5.47% |
| 2011-06-30 |
$0.03B |
$0.62B |
5.70% |
| 2011-03-31 |
$0.03B |
$0.60B |
5.46% |
| 2010-12-31 |
$0.03B |
$0.59B |
5.15% |
| 2010-09-30 |
$0.03B |
$0.58B |
4.83% |
| 2010-06-30 |
$0.02B |
$0.58B |
3.46% |
| 2010-03-31 |
$0.01B |
$0.58B |
2.44% |
| 2009-12-31 |
$0.01B |
$0.58B |
1.94% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$2.236B |
$1.245B |
|
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
|
